• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Alterations in concentrations of neurotransmitters in cerebrospinal fluid in patients with Parkinson's disease.

Research Project

Project/Area Number 03454243
Research Category

Grant-in-Aid for General Scientific Research (B)

Allocation TypeSingle-year Grants
Research Field Neurology
Research InstitutionIwata Medical University

Principal Investigator

TOHGI Hideo  Iwata Medical University Deparitment of Neurology, Professor, 医学部, 教授 (90155490)

Co-Investigator(Kenkyū-buntansha) TAKAHASHI Satoshi  Iwata Medical University Deparitment of Neurology, Lecturer, 医学部, 助手 (50216719)
ABE Takashi  Iwata Medical University Deparitment of Neurology, Lecturer, 医学部, 講師 (30202667)
Project Period (FY) 1991 – 1993
Project Status Completed (Fiscal Year 1993)
Budget Amount *help
¥6,500,000 (Direct Cost: ¥6,500,000)
Fiscal Year 1993: ¥700,000 (Direct Cost: ¥700,000)
Fiscal Year 1992: ¥1,500,000 (Direct Cost: ¥1,500,000)
Fiscal Year 1991: ¥4,300,000 (Direct Cost: ¥4,300,000)
KeywordsParkinson's disease / Dopamine / Norepinephrine / Serotonin / Glutamate / GABA / 3-O-methydopa / Kynurenine / tryptophan / Serotonin(5-HT) / 5-HIAA / cerebrospinal fluid / tyrosine / Lーdopa / dopamine / 3ーOーmthldopa
Research Abstract

Concentrations of catecholamines indolamines, and transmitter amino acids in cerebrospinal fluid from patients with Parkknson's desease(PD), and correlated with clinical symptoms, severity, and responses to L-dopa medication. Concentrations of norepinephrine, serotonin, gluramate, aspartate, and GABA were decreased in PD patients. The reduction in norepinephrine and serotonin concentrations was related to the severity of rigidity, akinesia, and gait freezing. The decrease in serotonin concentration was also related to the degrees of cognitive dysfunctions in L-dopa-treated PD patients. Administration of L-DOPS, a precursor of norepinephrine, reamarkably increased norepinephrine concentration and ameliorate gait freezing in some patients of moderate severities. These data provide a basis for our understanding of pathophysiology of PD.

Report

(4 results)
  • 1993 Annual Research Report   Final Research Report Summary
  • 1992 Annual Research Report
  • 1991 Annual Research Report
  • Research Products

    (38 results)

All Other

All Publications (38 results)

  • [Publications] Tohgi H: "A significant reduction of putative transmitter amino acid in cerebrospinal fluid of patients with Parkinson's disease and spinocerbellar degenration." Neurosci Lett. 126. 155-158 (1991)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Tohgi H: "Concentrations of tyrosine,L-dihydroxphenylalanine,dopamine,and 3-0-methyldopa in the cerebrospinal fluid of Parkinson's disease." Neurosci Lett. 127. 212-214 (1991)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Tohgi H: "The significance of 3-0-methyldopa concentrations in the cerebrospinal fluid in the pathogensis of wearing-off phenomenon in Parkinson's disease." Neurosci Lett. 132. 19-22 (1991)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Tohgi H: "Monoamine metabolism in the cerebrospinal fluid in Parkinson's disease:Relationship to clinical symptoms and subsequent therapeutic outcomes." J Neural Transm[P-D Sect]. 5. 17-26 (1993)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Tohgi H: "The effects of L-threo-3,4-dihydroxyphenylserine on the total norepinephrine and dopamine concentrations in the cerebrospinal fluid and freezing gait in parkinsonian patients." J Neural Transm[P-D Sect]. 5. 27-34 (1993)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Tohgi H: "The effect of age on the concentrations of monoamines,amino acids,and their related substances in the cerebrospinal fluid." J Neural Transm[P-D Sect]. 5. 215-226 (1993)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Tohgi H: "Concentrations of serotonin and its related substances in the cerebrospinal fluid of Parkinsonian patients and their relations to the severity of symptoms." Neurosci Lett. 150. 71-74 (1993)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Tohgi H: "Alterations in the concentration of serotonergic and dopaminergic substances in the cerebrospunal fluid of patients with Parkinson's disease and their changes after L-dopa administration." Neurosci Lett. 159. 135-138 (1993)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Tohgi H: "The urate and xannthine concentrations in the cerebrospinal fluid in patients with vascular dementia of the Binswanger type,Alzheimer type dementia,and Parkinson's disease." J Neural Transm[P-D Sect]. (1993)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Tohgi, H., Abe, T., Hashiguchi, K., Takahashi, S., Nozaki, Y., Kikuchi, T.: "A significant reduction of putative transmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease and spinocerbellar degenration." Neurosci Lett. 126. 155-158 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Tohgi, H., Abe, T., Takahashi, S., Nozaki, Y., Kikuchi, T.: "Concentrations of tyrosine, L-dihydroxphenylalanine, dopamine, and 3-0-methyldopa in the cerebrospinal fluid of Parkinson's disease." Neurosci Lett. 127. 212-214 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Tohgi, H., Abe, T., Kikuchi, T., Takahashi, S., Nozaki, Y.: "The significance of 3-0-methyldopa concentrations in the cefebrospinal fluid in the pathogensis of weraing-off phenomenon in Parkinson's disease." Neurosci Lett. 132. 19-22 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Tohgi, H., Abe, T., Takahashi, S., Takahashi, J., Nozaki, Y., Ueno, M., Kikuchi, T.: "Monoamine metabolism in the cerebrospinal fluid in Parkinson's disease : Relationship to clinical symptoms and subsequent therapeutic outcomes." J Neural Transm[P-D Sect]. 5. 17-26 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Tohgi, H., Abe, T., Takahashi, S.: "The effects of L-threo-3,3-dihydroxyphenylserine on the total norepinephrine and dopamine concentrations in the cerebrospinal fluid and freezing gait in parkinsonian patients." J Neural Transm[P-D Sect]. 5. 27-34 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Tohgi, H., Abe, T., Takahashi, S.: "The effect of age on the concentrations of monoamines, amino acids, and their related substances in the cerebrospinal fluid." J Neural Transm[P-D Sect]. 5. 215-226 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Tohgi, H., Abe, T., Takahashi, S., Takahashi, J., Hamato, H.: "Concentrations of serotonin and its related substances in the cerebrospinal fluid of Parkinsonian patients and their relations to the severity of symptoms." Neurosci Lett. 150. 71-74 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Tohgi, H., Abe, T., Takahashi, S., Takahashi, J., Hamato, H.: "Alterations in the concentration of serotonergic and dopaminergic substances in the cerebrospinal fluid of patients with Parkinson's disease and their changes after L-dopa administration." Neurosci Lett. 159. 135-138 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Tohgi, H., Abe, T., Kikuchi, T.: "The urate and xanthine concentrations in the cerebrospinal fluid in patients with vascular dementia of the Binswanger type, Alzheimer type dementia, and Parkinson's disease." J Neural Transm[P-D Sect]. 6. 119-126 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Tohgi H: "A slgnificant reduction of putative transmitter aminc in cerebrospinal fluid of patients with Parkinson's disease and spinocerbellar degenration." Neurosci,Lett. 126. 155-158 (1991)

    • Related Report
      1993 Annual Research Report
  • [Publications] Tohgi H: "Concentrations of tyrosine.L-dihydroxphenylalanine,dopamine,and 3-0-methyldopa in the cerebrospinal fluid of Parkinson's disease" Neurosci.Lett. 127. 212-214 (1991)

    • Related Report
      1993 Annual Research Report
  • [Publications] Tohgi H: "The significance of 3-0-methyldopa concentrations in the cerebrospinal gluid in the pathogensis of wearing-off phenomenon in Parkinson's disease." Neurosci.Lett. 132. 19-22 (1991)

    • Related Report
      1993 Annual Research Report
  • [Publications] Tohgi H: "Monoamine,metabolism in the cerebrospinal fluid in Parkinson's disease:Relationship to clinical symptome and subsequent the rapeutic outcmes." J.Neural Transm[P-D Sact]. 5. 17-26 (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] Tohgi H: "The effects of L-threo-3,4-dihydroxyphenylserine on the total norepinephrine and dopamine concentrations parkinsonlan patients." J.Neural Transm [R-D Sect]. 5. 27-34 (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] Tohgi H: "The effect of age on the concentrations of monoamines,amino acids,and their related;substances in the cerebrospinal fluid." J.Neural Transm[P-D Sect]. 5. 215-226 (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] Tohgi H: "Concentrations of serotonin and its related substances in the cerebrospinal fluid of Parkinsonian patients and their relations to the severity of symptoms." Neurosci,Lett. 150. 71-74 (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] Tohgi H: "Alterations in the concentration of serotonergic and dopaminergic substances in,the cerebrospunal fluid changes after L-dona aoministration." Neurosci,Lett. 159. 135-138 (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] Tohgi H: "The urate and xannthine concentrations in the cerebrospinal fluid in patients with vascular dementia of the Binswanger type,Alzheimer type dementia,and Parkinson's disease." J,Neural Transm[P-D Sect]. (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] Tohgi H: "A significant reduction of putative transmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease and spinocerebellar degeneration." Neurosci Lett. 126. 155-158 (1991)

    • Related Report
      1992 Annual Research Report
  • [Publications] Tohgi H: "Concentrations of tyrosine,L-dihydroxyphenylalanine,dopamine,and 3-0-methyldopa in the cerebrospinal fluid of Parkinson's disease." Neurosci Lett. 127. 212-214 (1991)

    • Related Report
      1992 Annual Research Report
  • [Publications] Tohgi H: "The significance of 3-0-methyldopa concentrations in the cerebrospinal fluid in the pathogenesis of wearing-off phenomenon in Parkinson's disease." Neurosci Lett. 132. 19-22 (1991)

    • Related Report
      1992 Annual Research Report
  • [Publications] Tohgi H: "Concentrations of monoamines and their metabolites in the cerebrospinal fluid from patients with senile dementia of the Alzheimer type and vascular dementia of The Binswanger type." J Neural Transmission P-D sect. 4. 69-77 (1992)

    • Related Report
      1992 Annual Research Report
  • [Publications] Tohgi H: "A selective reduction of excitatory amino acids in cerebrospinal fluid of patients with Alzheimer type dementia compared with vascular dementia of the Binswanger type." Neurosci Lett. 141. 5-8 (1992)

    • Related Report
      1992 Annual Research Report
  • [Publications] Tohgi H: "Concentrations of serotonin and its related substances in the cerebrospinal fluid in patients with Alzheimer type dementia." Neurosci Lett. 141. 9-12 (1992)

    • Related Report
      1992 Annual Research Report
  • [Publications] Tohgi H: "Effect of a synthetic norepinephrine precursor,Lーthreoー3,4 dihydroxyphenylserine on the total norepinephrine concentration in the cerebrospinal fluid of parkinsonian patients." Neurosci Lett. 116. 194-197 (1990)

    • Related Report
      1991 Annual Research Report
  • [Publications] Tohgi H: "Cerebrospinal fluid dopamine,Norepinephrine,and epinephrine concentrations in Parkinson's disease correlated with clinical symptoms." Adv Neurol. 53. 277-282 (1990)

    • Related Report
      1991 Annual Research Report
  • [Publications] Tohgi H: "A significant reduction of putative transmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease and spinocerebellar degeneration." Neurosci Lett. 126. 155-158 (1991)

    • Related Report
      1991 Annual Research Report
  • [Publications] Tohgi H: "Concentrations of tyrosine,Lーdihydroxyphenylalanine,dopamine,and 3ーOーmethyldopa in the cerebrospinal fluid of Parkinson's disease." Neurosci Lett. 127. 212-214 (1991)

    • Related Report
      1991 Annual Research Report
  • [Publications] Tohgi H: "The significance 3ーOーmethldopa concentrations in the cerebrospinal fluid in the pathogenesis of weraingーoff phenomenon in Parkinson's disease." Neurosci Lett. 132. 19-22 (1991)

    • Related Report
      1991 Annual Research Report

URL: 

Published: 1991-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi